Metabolic Surgery to Treat Obesity in Diabetic Kidney Disease, Chronic Kidney Disease, and End-Stage Kidney Disease; What Are the Unanswered Questions?

被引:34
作者
Martin, William P. [1 ]
White, James [1 ]
Lopez-Hernandez, Francisco J. [2 ]
Docherty, Neil G. [1 ]
le Roux, Carel W. [1 ,3 ]
机构
[1] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Sch Med, Diabet Complicat Res Ctr, Dublin, Ireland
[2] Hosp Virgen Vega, Inst Estudios Ciencias Salud Castilla & Leon, Inst Invest Biomed Salamanca IECSCYL IBSAL, Salamanca, Spain
[3] Imperial Coll London, Div Invest Sci, London, England
基金
英国惠康基金; 瑞典研究理事会; 英国医学研究理事会; 爱尔兰科学基金会;
关键词
obesity; metabolic surgery; type 2 diabetes mellitus; diabetic kidney disease; chronic kidney disease; end-stage kidney disease; kidney transplantation; dialysis; LAPAROSCOPIC-SLEEVE-GASTRECTOMY; Y-GASTRIC-BYPASS; INTENSIVE MEDICAL THERAPY; NONSURGICAL WEIGHT-LOSS; BODY-MASS INDEX; BARIATRIC SURGERY; RENAL-TRANSPLANTATION; PERITONEAL-DIALYSIS; BLOOD-PRESSURE; MORBID-OBESITY;
D O I
10.3389/fendo.2020.00289
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity is a major factor in contemporary clinical practice in nephrology. Obesity accelerates the progression of both diabetic and non-diabetic chronic kidney disease and, in renal transplantation, both recipient and donor obesity increase the risk of allograft complications. Obesity is thus a major driver of renal disease progression and a barrier to deceased and living donor kidney transplantation. Large observational studies have highlighted that metabolic surgery reduces the incidence of albuminuria, slows chronic kidney disease progression, and reduces the incidence of end-stage kidney disease over extended follow-up in people with and without type 2 diabetes. The surgical treatment of obesity and its metabolic sequelae has therefore the potential to improve management of diabetic and non-diabetic chronic kidney disease and aid in the slowing of renal decline toward end-stage kidney disease. In the context of patients with end-stage kidney disease, although complications of metabolic surgery are higher, absolute event rates are low and it remains a safe intervention in this population. Pre-transplant metabolic surgery increases access to kidney transplantation in people with obesity and end-stage kidney disease. Metabolic surgery also improves management of metabolic complications post-kidney transplantation, including new-onset diabetes. Procedure selection may be critical to mitigate the risks of oxalate nephropathy and disruption to immunosuppressant pharmacokinetics. Metabolic surgery may also have a role in the treatment of donor obesity, which could increase the living kidney donor pool with potential downstream impact on kidney paired exchange programmes. The present paper provides a comprehensive coverage of the literature concerning renal outcomes in clinical studies of metabolic surgery and integrates findings from relevant mechanistic pre-clinical studies. In so doing the key unanswered questions for the field are brought to the fore for discussion.
引用
收藏
页数:23
相关论文
共 190 条
[1]   Long-term mortality after gastric bypass surgery [J].
Adams, Ted D. ;
Gress, Richard E. ;
Smith, Sherman C. ;
Halverson, R. Chad ;
Simper, Steven C. ;
Rosamond, Wayne D. ;
LaMonte, Michael J. ;
Stroup, Antoinette M. ;
Hunt, Steven C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (08) :753-761
[2]   Kidney Disease and Increased Mortality Risk in Type 2 Diabetes [J].
Afkarian, Maryam ;
Sachs, Michael C. ;
Kestenbaum, Bryan ;
Hirsch, Irl B. ;
Tuttle, Katherine R. ;
Hinnmelfarb, Jonathan ;
de Boer, Ian H. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (02) :302-308
[3]   Bariatric Surgery as a Bridge to Renal Transplantation in Patients with End-Stage Renal Disease [J].
Al-Bahri, Shadi ;
Fakhry, Tannous K. ;
Gonzalvo, John Paul ;
Murr, Michel M. .
OBESITY SURGERY, 2017, 27 (11) :2951-2955
[4]   Changes in Lean Mass, Absolute and Relative Muscle Strength, and Physical Performance After Gastric Bypass Surgery [J].
Alba, Diana L. ;
Wu, Lucy ;
Cawthon, Peggy M. ;
Mulligan, Kathleen ;
Lang, Thomas ;
Patel, Sheena ;
King, Nicole J. ;
Carter, Jonathan T. ;
Rogers, Stanley J. ;
Posselt, Andrew M. ;
Stewart, Lygia ;
Shoback, Dolores M. ;
Schafer, Anne L. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (03) :711-720
[5]   Gastric bypass in chronic renal failure and renal transplant [J].
Alexander, J. Wesley ;
Goodman, Hope .
NUTRITION IN CLINICAL PRACTICE, 2007, 22 (01) :16-21
[6]   Diabetic Kidney Disease Challenges, Progress, and Possibilities [J].
Alicic, Radica Z. ;
Rooney, Michele T. ;
Tuttle, Katherine R. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (12) :2032-2045
[7]   INCREASED HYALURONIC-ACID IN THE INNER RENAL MEDULLA OF OBESE DOGS [J].
ALONSOGALICIA, M ;
DWYER, TM ;
HERRERA, GA ;
HALL, JE .
HYPERTENSION, 1995, 25 (04) :888-892
[8]   Safety analysis of primary bariatric surgery in patients on chronic dialysis [J].
Andalib, Amin ;
Aminian, Ali ;
Khorgami, Zhamak ;
Navaneethan, Sankar D. ;
Schauer, Philip R. ;
Brethauer, Stacy A. .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2016, 30 (06) :2583-2591
[9]  
Angrisani L, 2017, OBES SURG, V27, P2279, DOI 10.1007/s11695-017-2666-x
[10]   Bariatric Surgery or Non-Surgical Weight Loss for Obstructive Sleep Apnoea? A Systematic Review and Comparison of Meta-analyses [J].
Ashrafian, Hutan ;
Toma, Tania ;
Rowland, Simon P. ;
Harling, Leanne ;
Tan, Alan ;
Efthimiou, Evangelos ;
Darzi, Ara ;
Athanasiou, Thanos .
OBESITY SURGERY, 2015, 25 (07) :1239-1250